Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care

Abstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These P...

Full description

Bibliographic Details
Main Authors: Brian G. Beitler, Paul F. Abraham, Alyssa R. Glennon, Steven M. Tommasini, Lisa L. Lattanza, Jonathan M. Morris, Daniel H. Wiznia
Format: Article
Language:English
Published: BMC 2022-02-01
Series:3D Printing in Medicine
Subjects:
Online Access:https://doi.org/10.1186/s41205-022-00134-y
_version_ 1798023792530817024
author Brian G. Beitler
Paul F. Abraham
Alyssa R. Glennon
Steven M. Tommasini
Lisa L. Lattanza
Jonathan M. Morris
Daniel H. Wiznia
author_facet Brian G. Beitler
Paul F. Abraham
Alyssa R. Glennon
Steven M. Tommasini
Lisa L. Lattanza
Jonathan M. Morris
Daniel H. Wiznia
author_sort Brian G. Beitler
collection DOAJ
description Abstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed devices through existing medical device regulations. However, the FDA is increasingly interested in developing guidelines and regulations specifically for PoC 3D printing due to its rapid adoption across the healthcare institutions. In this article, we review the regulatory framework that governs medical devices, discuss how PoC 3D printing falls within this framework, and describe a novel conceptual framework that the FDA has proposed. Finally, through analysis of the aforementioned regulations and discussions with industry medical 3D printing regulatory experts, we provide recommendations for PoC medical 3D printing best practices so that institutions are best positioned to utilize this revolutionary technology safely and effectively.
first_indexed 2024-04-11T17:52:05Z
format Article
id doaj.art-74dc26b83ed44ba593ad8982875ed057
institution Directory Open Access Journal
issn 2365-6271
language English
last_indexed 2024-04-11T17:52:05Z
publishDate 2022-02-01
publisher BMC
record_format Article
series 3D Printing in Medicine
spelling doaj.art-74dc26b83ed44ba593ad8982875ed0572022-12-22T04:11:01ZengBMC3D Printing in Medicine2365-62712022-02-01811710.1186/s41205-022-00134-yInterpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of careBrian G. Beitler0Paul F. Abraham1Alyssa R. GlennonSteven M. Tommasini2Lisa L. Lattanza3Jonathan M. Morris4Daniel H. Wiznia5Department of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Orthopaedic Surgery, Keck School of Medicine of USCDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineDepartment of Radiology, The Mayo ClinicDepartment of Orthopaedics and Rehabilitation, Yale School of MedicineAbstract 3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed devices through existing medical device regulations. However, the FDA is increasingly interested in developing guidelines and regulations specifically for PoC 3D printing due to its rapid adoption across the healthcare institutions. In this article, we review the regulatory framework that governs medical devices, discuss how PoC 3D printing falls within this framework, and describe a novel conceptual framework that the FDA has proposed. Finally, through analysis of the aforementioned regulations and discussions with industry medical 3D printing regulatory experts, we provide recommendations for PoC medical 3D printing best practices so that institutions are best positioned to utilize this revolutionary technology safely and effectively.https://doi.org/10.1186/s41205-022-00134-y3D PrintingOrthopedicsFDAPoint-of-care (PoC) 3D PrintingMedical device design
spellingShingle Brian G. Beitler
Paul F. Abraham
Alyssa R. Glennon
Steven M. Tommasini
Lisa L. Lattanza
Jonathan M. Morris
Daniel H. Wiznia
Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
3D Printing in Medicine
3D Printing
Orthopedics
FDA
Point-of-care (PoC) 3D Printing
Medical device design
title Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
title_full Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
title_fullStr Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
title_full_unstemmed Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
title_short Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
title_sort interpretation of regulatory factors for 3d printing at hospitals and medical centers or at the point of care
topic 3D Printing
Orthopedics
FDA
Point-of-care (PoC) 3D Printing
Medical device design
url https://doi.org/10.1186/s41205-022-00134-y
work_keys_str_mv AT briangbeitler interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT paulfabraham interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT alyssarglennon interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT stevenmtommasini interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT lisallattanza interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT jonathanmmorris interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare
AT danielhwiznia interpretationofregulatoryfactorsfor3dprintingathospitalsandmedicalcentersoratthepointofcare